SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Nicotine Patch Plus Lozenge Best for Quitting Smoking, National Institutes of Health (NIH) Funded Study
November 3, 2009
 · 
1 min read
Drug Development
Certain Antibiotics May Up Birth Defect Risk, Centers for Disease Control and Prevention (CDC) Study
November 3, 2009
 · 
1 min read
Drug Development
Extending Treatment After Liver Transplant May Benefit Patients With Hepatitis C Recurrence, Henry Ford Hospital Study
November 2, 2009
 · 
1 min read
Drug Development
Switching Immunosuppressants Reduces Cancer Risk In Kidney, Queen Elizabeth Hospital Study
November 2, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Triple-combo Drug Shows Promise Against Antiviral-resistant H1N1, University of Alabama at Birmingham Study
October 30, 2009
 · 
1 min read
Drug Development
Teriparatide Outperforms Alendronate In Treating Steroid-Induced Osteoporosis, University of Alabama at Birmingham Study
October 29, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Antipsychotics Cause Rapid Weight Gain in Youth, Zucker Hillside Hospital and Feinstein Institute for Medical Research Study
October 28, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Anti-Epilepsy Drugs Could Treat Alzheimer’s And Parkinson’s Diseases, Washington University in St. Louis Study
October 28, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Combination Antiretroviral Therapy Effective At Reducing HIV Resistance In Mothers And Babies Following Mother-to-child Transmission, Study Funded by Boehringer Ingelheim Corporation
October 28, 2009
 · 
1 min read
Drug Development
Drug Used For Neuropathic Pain Relieves Discomfort From Abdominal Adhesions, Henry Ford Hospital Study
October 27, 2009
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Boehringer Ingelheim Release: New Data Show High Adherence Rates With Pradaxa (Dabigatran Etexilate Mesylate) In NVAF Patients
December 5, 2016
 · 
9 min read
Drug Development
Sorrento Subsidiary, Scilex Announces Key Endpoints Met In Pivotal Bioequivalence Clinical Study For Its Lead Product, ZTlido
December 5, 2016
 · 
5 min read
Drug Development
Mallinckrodt Release: Clinical Pharmacokinetic And Health Economic Data On OFIRMEV (Acetaminophen) Injection Presented At 15th Annual Pain Medicine Meeting Of ASRA
November 18, 2016
 · 
11 min read
Drug Development
New Analysis Of Novartis AG’ Entresto Data Shows Long-Term Benefits On Heart Failure Readmissions And Total Cardiovascular Deaths
November 16, 2016
 · 
12 min read
Drug Development
UCB, Inc. Release: The Lancet Publishes First Head-To-Head Study Of CIMZIA (Certolizumab Pegol) And Humira (Adalimumab) In Bio-Naïve Rheumatoid Arthritis Patients
November 15, 2016
 · 
12 min read
Drug Development
First Patient Enrolled In Mallinckrodt Phase 4 Trial Of H.P. Acthar Gel For Lupus
November 15, 2016
 · 
8 min read
Drug Development
Bristol-Myers Squibb Showcases Rheumatoid Arthritis And Immunoscience Commitment With Depth Of Research At 2016 American College of Rheumatology And Association Of Rheumatology Health Professionals Annual Meeting
November 14, 2016
 · 
13 min read
Drug Development
Bayer Release: 20+ Years Of Safety Data, Clinical Trials & Real-World Use Confirm Positive Benefit/Risk Profile Of ALEVE
November 14, 2016
 · 
4 min read
Drug Development
Eli Lilly Release: New Analyses Of Phase 3 Trials Show Improvements In Rheumatoid Arthritis Symptoms Following Treatment With Baricitinib Across Diverse Population Of Patients
November 14, 2016
 · 
11 min read
Drug Development
Janssen Biotech Release: Two Studies Reveal Differences In Real-World Treatment Patterns In Rheumatoid Arthritis Patients Taking REMICAD (infliximab) Compared To CT-P13 (infliximab biosimilar)
November 14, 2016
 · 
11 min read
Drug Development
Horizon Pharma Presents Data On KRYSTEXXA (Pegloticase) For The Management Of Refractory Chronic Gout At The 2016 ACR/ARHP Annual Meeting
November 14, 2016
 · 
10 min read
Drug Development
Eli Lilly Release: Baricitinib Demonstrates Early Response Compared To Placebo And Significant Improvement Compared To Adalimumab In Patient-Reported Outcomes
November 14, 2016
 · 
9 min read
Drug Development
First Patient Enrolled In Mallinckrodt Phase 4 Trial Of H.P. Acthar Gel For Rheumatoid Arthritis
November 14, 2016
 · 
8 min read
Drug Development
Eli Lilly Release: Jardiance (Empagliflozin) Consistently Reduced The Risk Of Cardiovascular Death In Adults With Type 2 Diabetes Regardless Of The Type Of Cardiovascular Disease At Baseline
November 14, 2016
 · 
12 min read
Drug Development
Sunovion Announces Positive Clinical Study Results For Latuda (Lurasidone HCL) In Adolescents With Schizophrenia
October 27, 2016
 · 
13 min read
Drug Development
Imprimis’ Dropless Therapy Shows Significant Advantages In A Large Peer-Reviewed Study
October 25, 2016
 · 
6 min read
Drug Development
Janssen Pharmaceutical Release: Two New Real-World Studies Confirm Positive Efficacy And Safety Profile Of XARELTO (Rivaroxaban) In Treating And Preventing Blood Clots
October 24, 2016
 · 
16 min read
Drug Development
Boehringer Ingelheim Release: New Real-World Data Show Pradaxa (Dabigatran Etexilate Mesylate) Treatment Resulted In Less Use Of All-Cause Healthcare Resources Than Warfarin Treatment
October 21, 2016
 · 
8 min read
Drug Development
Takeda’s Vedolizumab Demonstrated Robust Clinical Effectiveness And Safety In Inflammatory Bowel Disease In More Than 50 Real-World Studies
October 17, 2016
 · 
11 min read
Drug Development
Amgen Release: New Retrospective Analyses Confirm Vectibix (Panitumumab) Treatment Provided Survival Benefit Over Chemotherapy With Or Without Bevacizumab In Metastatic Colorectal Cancer Patients With Tumors Of Left-Sided Origin
October 10, 2016
 · 
21 min read
Load More